simplehuman (UK) Limited 04896417 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is that of the import and selling of tools for efficient living. Digita Accounts Production Advanced 6.30.9574.0 true true true false 04896417 2024-01-01 2024-12-31 04896417 2024-12-31 04896417 bus:Director4 2024-12-31 04896417 bus:OrdinaryShareClass1 2024-12-31 04896417 core:AcceleratedTaxDepreciationDeferredTax 2024-12-31 04896417 core:ProvisionsDeferredTax 2024-12-31 04896417 core:RetirementBenefitObligationsDeferredTax 2024-12-31 04896417 core:RetainedEarningsAccumulatedLosses 2024-12-31 04896417 core:ShareCapital 2024-12-31 04896417 core:CurrentFinancialInstruments 2024-12-31 04896417 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 04896417 core:CurrentFinancialInstruments core:WithinOneYear 2 2024-12-31 04896417 core:BetweenTwoFiveYears 2024-12-31 04896417 core:WithinOneYear 2024-12-31 04896417 core:FurnitureFittingsToolsEquipment 2024-12-31 04896417 core:LandBuildings 2024-12-31 04896417 core:OtherPropertyPlantEquipment 2024-12-31 04896417 core:DeferredTaxation 2024-12-31 04896417 core:OtherProvisionsContingentLiabilities 2024-12-31 04896417 core:Warranties 2024-12-31 04896417 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-12-31 04896417 core:ParentEntities 2024-12-31 04896417 bus:FRS102 2024-01-01 2024-12-31 04896417 bus:Audited 2024-01-01 2024-12-31 04896417 bus:FullAccounts 2024-01-01 2024-12-31 04896417 bus:RegisteredOffice 2024-01-01 2024-12-31 04896417 bus:CompanySecretary1 2024-01-01 2024-12-31 04896417 bus:Director1 2024-01-01 2024-12-31 04896417 bus:Director3 2024-01-01 2024-12-31 04896417 bus:Director4 2024-01-01 2024-12-31 04896417 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 04896417 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04896417 bus:Agent1 2024-01-01 2024-12-31 04896417 2 2024-01-01 2024-12-31 04896417 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 04896417 core:ShareCapital 2024-01-01 2024-12-31 04896417 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 04896417 core:LandBuildings 2024-01-01 2024-12-31 04896417 core:LeaseholdImprovements 2024-01-01 2024-12-31 04896417 core:OfficeEquipment 2024-01-01 2024-12-31 04896417 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 04896417 core:PlantMachinery 2024-01-01 2024-12-31 04896417 core:DeferredTaxation 2024-01-01 2024-12-31 04896417 core:OtherProvisionsContingentLiabilities 2024-01-01 2024-12-31 04896417 core:Warranties 2024-01-01 2024-12-31 04896417 core:KeyManagementPersonnel 2024-01-01 2024-12-31 04896417 core:ParentEntities 2024-01-01 2024-12-31 04896417 core:UKTax 2024-01-01 2024-12-31 04896417 1 2024-01-01 2024-12-31 04896417 countries:AllCountries 2024-01-01 2024-12-31 04896417 2023-12-31 04896417 core:RetainedEarningsAccumulatedLosses 2023-12-31 04896417 core:ShareCapital 2023-12-31 04896417 core:FurnitureFittingsToolsEquipment 2023-12-31 04896417 core:LandBuildings 2023-12-31 04896417 core:OtherPropertyPlantEquipment 2023-12-31 04896417 core:DeferredTaxation 2023-12-31 04896417 core:OtherProvisionsContingentLiabilities 2023-12-31 04896417 core:Warranties 2023-12-31 04896417 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-12-31 04896417 core:ParentEntities 2023-12-31 04896417 2023-01-01 2023-12-31 04896417 2023-12-31 04896417 bus:OrdinaryShareClass1 2023-12-31 04896417 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 04896417 core:ProvisionsDeferredTax 2023-12-31 04896417 core:RetirementBenefitObligationsDeferredTax 2023-12-31 04896417 core:TaxLossesCarry-forwardsDeferredTax 2023-12-31 04896417 core:CurrentFinancialInstruments 2023-12-31 04896417 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 04896417 core:CurrentFinancialInstruments core:WithinOneYear 2 2023-12-31 04896417 core:BetweenTwoFiveYears 2023-12-31 04896417 core:WithinOneYear 2023-12-31 04896417 core:FurnitureFittingsToolsEquipment 2023-12-31 04896417 core:LandBuildings 2023-12-31 04896417 core:OtherPropertyPlantEquipment 2023-12-31 04896417 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-12-31 04896417 core:ParentEntities 2023-12-31 04896417 2 2023-01-01 2023-12-31 04896417 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 04896417 core:ShareCapital 2023-01-01 2023-12-31 04896417 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-01-01 2023-12-31 04896417 core:UKTax 2023-01-01 2023-12-31 04896417 2022-12-31 04896417 core:RetainedEarningsAccumulatedLosses 2022-12-31 04896417 core:ShareCapital 2022-12-31 04896417 core:ParentEntities 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04896417

simplehuman (UK) Limited

Annual Report and Financial Statements

for the Year Ended 31 December 2024

 

simplehuman (UK) Limited

Contents

Company Information

1

Strategic Report

2

Directors' Report

3 to 4

Statement of Directors' Responsibilities

5

Independent Auditor's Report

6 to 8

Statement of Comprehensive Income

9

Statement of Financial Position

10

Statement of Changes in Equity

11

Statement of Cash Flows

12

Notes to the Financial Statements

13 to 24

 

simplehuman (UK) Limited

Company Information

Directors

F S P Yang

J R Dowdeswell

K K Yen

Company secretary

J R Dowdeswell

Registered office

Level 3 Warehouse
1 Fleur De Lis Passage
London
E1 6RB

Auditors

Sansum & Co Limited 1 Meadow View
High Street
Burbage
Marlborough
SN8 3AF

 

simplehuman (UK) Limited

Strategic Report for the Year Ended 31 December 2024

The directors present their strategic report for the year ended 31 December 2024.

Principal activity

The principal activity of the company is that of the import and selling of tools for efficient living.

Fair review of the business

Turnover remained steady during 2024 at £ 26,897,995 (2023, £26,603,307) and profit before tax was 2024
£378,685 (2023 - £585,109). The company anticipates continued revenue growth in UK market in 2025.

Principal risks and uncertainties

The company has established risk review procedures to evaluate the company's risk appetite. The principle risks and uncertainties facing the company are broadly grouped as - economic, price, competitive and financial risk.

Economic Risks
The economic outlook in our principal markets remains uncertain. Difficult export conditions, tighter capacity in resources such as labour and property, and global shipping problems are all still dragging on profitability. Pricing and margins are monitored closely.

Price risks
Pricing is subject to three contributory factors; raw material cost, exchange rates and freight charges. These are
subject to regular internal reviews.

Competitive Risks
Risks to the brand are increasing due to the proliferation of design copies from the Far East and competitor incursion into simplehuman’s core product sectors. These are being actively managed by the company.

Financial Risks
The company continues to develop its risk and financial management framework. The objectives aim to ensure robust decision making and considered governance. The policies also determine the appropriate level of working capital exists and monitor the management of financial risk at a business unit level. This is achieved through proper levels of review and transactional authorisation. Additionally, simplehuman operates an IT security policy that mitigates conflict of interest.

Approved and authorised by the Board on 26 September 2025 and signed on its behalf by:
 

.........................................
J R Dowdeswell
Director

 

simplehuman (UK) Limited

Directors' Report for the Year Ended 31 December 2024

The directors present their report and the financial statements for the year ended 31 December 2024.

Directors of the company

The directors who held office during the year were as follows:

F S P Yang

J R Dowdeswell

K K Yen (appointed 13 November 2024)

Financial instruments

Objectives and policies

The company has established a risk and financial management framework whose primary objectives are to
protect the company from events that hinder the achievement of the company's performance objectives.

Price risk, credit risk, liquidity risk and cash flow risk

Price risk arises on financial instruments because of changes in, for example commodity prices or equity
prices. Given that the company is privately owned and is funded entirely from its own reserves and parent
company loans and does not hold investments, the company is not exposed to significant financial instrument
price fluctuations.

Credit risk is the risk that one party to a financial instrument will cause a financial loss for that other party by
failing to discharge an obligation. Company policies are aimed at minimising such losses. The company's
policies require appropriate credit checks on potential customers and suppliers before sales or purchases are made. The amount of exposure to any individual counterparty is subject to a limit, which is reviewed periodically.

Liquidity risk is the risk that an entity will encounter difficulty in meeting obligations associated with financial
liabilities. The company aims to mitigate liquidity risk by managing cash generation by its operations and
applying cash collection targets. Management review is conducted monthly and monitors financial statements,
cash flow and commercial operations.

Cash flow risk is the risk of exposure to variability in cash flows. The company manages this risk through
monthly management reviews of financial statements, cash flow and commercial operations.

Future developments

The director's aim to maintain and improve the management policies which have resulted in the company's substantial growth in recent years. The director anticipates continued growth in the EMEA markets in the coming years as the brand recognition grows.

Directors' liabilities

The company has granted an indemnity to the director against liability in respect of proceedings brought by third parties, subject to the conditions set out in the Companies Act 2006. Such qualifying third party indemnity provision remains in force as at the date of approving the director's report.

Disclosure of information to the auditors

 

simplehuman (UK) Limited

Directors' Report for the Year Ended 31 December 2024

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Reappointment of auditors

The auditors Sansum & Co Limited are deemed to be reappointed under section 487(2) of the Companies Act 2006.

Approved and authorised by the Board on 26 September 2025 and signed on its behalf by:
 

.........................................
J R Dowdeswell
Director

 

simplehuman (UK) Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

simplehuman (UK) Limited

Independent Auditor's Report to the Members of simplehuman (UK) Limited

Opinion

We have audited the financial statements of simplehuman (UK) Limited (the 'company') for the year ended 31 December 2024, which comprise the Statement of Comprehensive Income, Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Statement of Cash Flows, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

simplehuman (UK) Limited

Independent Auditor's Report to the Members of simplehuman (UK) Limited

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities [set out on page 5], the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

 

simplehuman (UK) Limited

Independent Auditor's Report to the Members of simplehuman (UK) Limited

We obtained an understanding of the legal and regulatory frameworks that are applicable to the entity and determined that the most significant are those that relate to employment law, pension regulation, health and safety regulation, general data protection regulation (GDPR), the waste electrical and electronic equipment directive (WEEE) and the Companies Act 2006.

We evaluated management's incentives and opportunities for fraudulent manipulation of the financial statements including the potential for management to override controls and determined the principal risks were related to the over statement of revenue, the understatement of expenses, the inappropriate netting of current assets and current liabilities and the misappropriation of stock.

In response to such risks we have performed specific procedures which included:

- Discussions with those charged with governance and other senior management;
- Analytical review of the financial statements;
- Review of key assumptions and judgements made by management with regard to significant accounting estimates;
- Identifying and testing of unusual journal entries throughout the year and around the year end.

There are inherent limitations in the audit procedures described above. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one caused by error as fraud may be deliberately concealed through intentional misrepresentation or concealment.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
M Sansum FCA (Senior Statutory Auditor)
For and on behalf of Sansum & Co Limited, Statutory Auditor
 1 Meadow View
High Street
Burbage
Marlborough
SN8 3AF

30 September 2025

 

simplehuman (UK) Limited

Statement of Comprehensive Income for the Year Ended 31 December 2024

Note

2024
£

2023
£

Turnover

3

26,897,995

26,603,307

Cost of sales

 

(14,300,721)

(14,474,149)

Gross profit

 

12,597,274

12,129,158

Distribution costs

 

(6,179,380)

(6,175,028)

Administrative expenses

 

(5,902,181)

(5,483,561)

Operating profit

4

515,713

470,569

Other interest receivable and similar income

5

5,732

208

Interest payable and similar expenses

6

(142,760)

114,332

   

(137,028)

114,540

Profit before tax

 

378,685

585,109

Tax on profit

10

(88,596)

(135,332)

Profit for the financial year

 

290,089

449,777

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

 

simplehuman (UK) Limited

(Registration number: 04896417)
Statement of Financial Position as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

11

97,192

39,071

Current assets

 

Stocks

12

7,116,980

5,973,253

Debtors

13

4,136,011

2,170,097

Cash at bank and in hand

 

1,149,984

599,823

 

12,402,975

8,743,173

Creditors: Amounts falling due within one year

15

(7,575,133)

(4,167,311)

Net current assets

 

4,827,842

4,575,862

Total assets less current liabilities

 

4,925,034

4,614,933

Provisions for liabilities

16

(274,110)

(254,098)

Net assets

 

4,650,924

4,360,835

Capital and reserves

 

Called up share capital

5,000

5,000

Retained earnings

4,645,924

4,355,835

Shareholders' funds

 

4,650,924

4,360,835

Approved and authorised by the Board on 26 September 2025 and signed on its behalf by:
 

.........................................
J R Dowdeswell
Director

 

simplehuman (UK) Limited

Statement of Changes in Equity for the Year Ended 31 December 2024

Share capital
£

Retained earnings
£

Total
£

At 1 January 2024

5,000

4,355,835

4,360,835

Profit for the year

-

290,089

290,089

Total comprehensive income

-

290,089

290,089

At 31 December 2024

5,000

4,645,924

4,650,924

Share capital
£

Retained earnings
£

Total
£

At 1 January 2023

5,000

3,906,058

3,911,058

Profit for the year

-

449,777

449,777

Total comprehensive income

-

449,777

449,777

At 31 December 2023

5,000

4,355,835

4,360,835

 

simplehuman (UK) Limited

Statement of Cash Flows for the Year Ended 31 December 2024

Note

2024
£

2023
£

Cash flows from operating activities

Profit for the year

 

290,089

449,777

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

4

27,676

20,962

Finance income

5

(5,732)

(208)

Finance costs

6

15,143

3,630

Income tax expense

10

88,596

135,332

 

415,772

609,493

Working capital adjustments

 

(Increase)/decrease in stocks

12

(1,143,727)

1,377,008

Increase in trade debtors

13

(2,106,405)

(133,649)

Increase/(decrease) in trade creditors

15

1,843,048

(1,502,334)

Increase in provisions

16

36,680

23,914

Cash generated from operations

 

(954,632)

374,432

Income taxes received/(paid)

10

100,000

(100,000)

Net cash flow from operating activities

 

(854,632)

274,432

Cash flows from investing activities

 

Interest received

5

5,732

208

Acquisitions of tangible assets

(85,796)

(17,075)

Net cash flows from investing activities

 

(80,064)

(16,867)

Cash flows from financing activities

 

Interest paid

6

(15,143)

(3,630)

Proceeds from other borrowing draw downs

 

1,500,000

-

Net cash flows from financing activities

 

1,484,857

(3,630)

Net increase in cash and cash equivalents

 

550,161

253,935

Cash and cash equivalents at 1 January

 

599,823

345,888

Cash and cash equivalents at 31 December

 

1,149,984

599,823

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Level 3 Warehouse
1 Fleur De Lis Passage
London
E1 6RB
United Kingdom

These financial statements were authorised for issue by the Board on 26 September 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Grants are accounted for using the the performance based model.

The company recognises grant income when:
The grant proceeds are received (or receivable) provided that the terms of the grant do not impose future performance-related conditions; or
performance-related conditions are met.

Any grants that are received before the revenue recognition criteria are met are recognised in the company's financial statements as a liability.

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold improvements

20% Straight line

Plant and machinery

20% Straight line

Furniture, fittings and equipment

20% Straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Provisions

Provisions are recognised when the company has an obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

3

Revenue

The analysis of the company's revenue for the year from continuing operations is as follows:

2024
 £

2023
 £

Sale of goods

26,897,995

26,603,307

In the director's opinion geographical analysis would be seriously prejudicial to the the company and therefore this analysis has been omitted.

4

Operating profit

Arrived at after charging/(crediting)

2024
 £

2023
 £

Depreciation expense

27,676

20,962

Included within adminstration expenses are exceptional costs totalling £Nil (2023: £462,212). £247,212 was paid in 2023 and related to proprty rental increases that were agreed during the year but related to 2021 and 2022 financial years. As the directors could not reliably estimate the increases these had not previously been accrued.

During 2023, the remaining cost of £215,000 related to a settlement required to exit a contract. It is not expected to incur similiar costs in the future.

5

Other interest receivable and similar income

2024
 £

2023
 £

Interest income on bank deposits

5,732

208

6

Interest payable and similar expenses

2024
 £

2023
 £

Interest on bank overdrafts and borrowings

2,243

3,630

Interest expense on other finance liabilities

12,900

-

Foreign exchange gains/losses

127,617

(117,962)

142,760

(114,332)

7

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

2024
 £

2023
 £

Wages and salaries

1,829,707

1,820,527

Social security costs

164,709

170,512

Other short-term employee benefits

5,043

4,956

Pension costs, defined contribution scheme

48,106

44,970

Other employee expense

147,224

124,271

2,194,789

2,165,236

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2024
No.

2023
No.

Administration and support

53

54

53

54

8

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
 £

2023
 £

Remuneration

185,218

182,005

Contributions paid to money purchase schemes

4,862

4,340

190,080

186,345

9

Auditors' remuneration

2024
 £

2023
 £

Audit of the financial statements

12,749

12,533


 

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

10

Taxation

Tax charged/(credited) in the statement of comprehensive income

2024
£

2023
£

Current taxation

UK corporation tax

64,774

-

Deferred taxation

Arising from origination and reversal of timing differences

23,822

135,332

Tax expense in the income statement

88,596

135,332

The tax on profit before tax for the year is the same as the standard rate of corporation tax in the UK (2023 - the same as the standard rate of corporation tax in the UK) of 25% (2023 - 25%).

The differences are reconciled below:

2024
£

2023
£

Profit before tax

378,685

585,109

Corporation tax at standard rate

94,671

146,277

Tax decrease from effect of capital allowances and depreciation

(3,061)

(5,491)

Tax decrease from other short-term timing differences

(742)

(1,253)

Effect of expense not deductible in determining taxable profit (tax loss)

34

37

Effect of tax losses

(26,128)

(85,820)

Deferred tax expense from unrecognised tax loss or credit

23,822

81,582

Total tax charge

88,596

135,332

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

Deferred tax

Deferred tax assets and liabilities

2024

Asset
£

Liability
£

Timing differences from the effect of capital allowances and depreciation

-

16,623

Unpaid pension contributions

-

(2,310)

General provisions

-

(11,309)

-

3,004

2023

Asset
£

Liability
£

Timing differences from the effect of capital allowances and depreciation

-

19,671

Unpaid pension contributions

2,066

-

General provisions

12,296

-

Tax losses carried forward

26,129

-

40,491

19,671

11

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2024

275,539

318,623

337,926

932,088

Additions

67,130

16,069

2,597

85,796

At 31 December 2024

342,669

334,692

340,523

1,017,884

Depreciation

At 1 January 2024

269,934

291,213

331,918

893,065

Charge for the year

12,887

10,905

3,835

27,627

At 31 December 2024

282,821

302,118

335,753

920,692

Carrying amount

At 31 December 2024

59,848

32,574

4,770

97,192

At 31 December 2023

5,605

27,458

6,008

39,071

Included within the net book value of land and buildings above is £59,847 (2023 - £5,605) in respect of short leasehold land and buildings.
 

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

12

Stocks

2024
 £

2023
 £

Finished goods and goods for resale

7,116,980

5,973,253

13

Debtors

Current

Note

2024
£

2023
£

Trade debtors

 

3,792,906

1,657,557

Other debtors

 

22,769

500

Prepayments

 

320,336

371,549

Deferred tax assets

10

-

40,491

Income tax asset

10

-

100,000

   

4,136,011

2,170,097

14

Cash and cash equivalents

2024
 £

2023
 £

Cash at bank

1,141,534

591,534

Short-term deposits

8,450

8,289

1,149,984

599,823

15

Creditors

Note

2024
 £

2023
 £

Due within one year

 

Trade creditors

 

3,339,799

1,376,845

Amounts due to related parties

22

1,655,314

155,314

Social security and other taxes

 

197,071

199,591

Outstanding defined contribution pension costs

 

9,241

8,263

Other payables

 

-

19,558

Accrued expenses

 

2,308,934

2,407,740

Income tax liability

10

64,774

-

 

7,575,133

4,167,311

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

16

Provisions for liabilities

Warranties
£

Deferred tax
£

Other provisions
£

Total
£

At 1 January 2024

42,427

19,671

192,000

254,098

Increase (decrease) in existing provisions

-

-

36,680

36,680

Provisions used

-

(16,668)

-

(16,668)

At 31 December 2024

42,427

3,003

228,680

274,110

Warranties
A provision has been included for the potential return of goods under the companys various warranty schemes based on an analysis of returns in prior years.

Deferred Tax
A provision for tax is recognised due to timing differences between the accounting profit and profit chargeable to corporation tax caused by accelerated capital allowances.

Dilapidations
A provision has been made for the cost of returning the offices and warehousing to their original states when the leases expires. The cost will only be incurred at the point the leases are not renewed.

17

Pension and other schemes

Defined contribution pension scheme

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £48,106 (2023 - £44,970).

Contributions totalling £9,241 (2023 - £8,263) were payable to the scheme at the end of the year and are included in creditors.

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

18

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary share of £1 each

5,000

5,000

5,000

5,000

       

Rights, preferences and restrictions

Ordinary Shares have the following rights, preferences and restrictions:
The holders of ordinary shares are entitled to receive dividends as declared from time to time and are entitled to one vote per share at meetings of the company. All ordinary shares rank equally with regard to the Company's residual assets.

Called-up share capital represents the nominal value of shares that have been issued.

19

Loans and borrowings

Other borrowings

The Intercompany loan of £1,500,000 (note 15) is denominated in GBP with a nominal interest rate of 7.2%. The carrying amount at year end is £1,500,000 (2023 - £Nil).

The loan is secured by way of a floating charge over all assets of the company.
Repayment is due on the 18 November 2025

20

Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

2024
£

2023
£

Not later than one year

61,367

-

Later than one year and not later than five years

1,247,233

1,662,548

1,308,600

1,662,548

The amount of non-cancellable operating lease payments recognised as an expense during the year was £990,185 (2023 - £640,151).

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

21

Financial guarantee contracts

The company provides a range of warranties at the time of sale to their customers. Under the terms of the contracts the company undertakes to make good, by repair or replacement, manufacturing defects that become apparent within one to ten years from the date of sale depending on the product sold.

The directors of the company have calculatated the expected outflow of resources to service warranty claims of products that are currently within their warranty period and have provided for the expected cost.

22

Related party transactions

Loans to related parties

2024

Key management
£

Total
£

At start of period

12,600

12,600

At end of period

12,600

12,600

2023

Key management
£

Total
£

Advanced

12,600

12,600

At end of period

12,600

12,600

Terms of loans to related parties

The interest free loan has been repaid in January 2025.
 

Loans from related parties

2024

Parent
£

Total
£

At start of period

155,314

155,314

Advanced

1,500,000

1,500,000

At end of period

1,655,314

1,655,314

2023

Parent
£

Total
£

At start of period

155,314

155,314

At end of period

155,314

155,314

Terms of loans from related parties

The intercompany loan of £1,500,000 is repayable within 12 months. Interest is charged at 7.2%. The loan is secured by way of a floating charge over the assets of the company. The remaining loan of £155,314 is an interest free, unsecured loan that is repayable on demand.
 

 

simplehuman (UK) Limited

Notes to the Financial Statements for the Year Ended 31 December 2024

23

Parent and ultimate parent undertaking

The largest and smallest group of undertakings which prepare consolidated financial statements including this company is headed by simplehuman, LLC a privately owned company in the US.

 The company's immediate parent is simplehuman, LLC, incorporated in the US.

 The ultimate controlling party is Mr F. Yang.